Khatri Vikalp, Mehrotra Megha Kohli, Kohli Monica, Malik Anita, Verma Anupam
Department of Anaesthesiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Department of Anaesthesiology, Institute of Liver and Biliary Diseases, New Delhi, India.
Anesth Essays Res. 2021 Jul-Sep;15(3):279-284. doi: 10.4103/aer.aer_136_21. Epub 2022 Feb 7.
Hemostatic abnormalities are more common in patients with brain tumors than systemic malignant diseases. Conventional coagulation tests (CCT) are poor assays for dynamic assessment of clot strength in whole blood. Thromboelastography (TEG) gives us detailed information on the dynamics of clot development, stabilization, and dissolution reflecting hemostasis. TEG can assess both thrombosis and fibrinolysis.
This study aimed to investigate the temporal trends in hemostatic profile occurring during surgery for primary brain tumors, using a combination of TEG and CCT, and to assess perioperative blood component support.
A prospective, observational study was done on 40 patients with primary brain tumors larger than 4 cm in maximum diameter on computed tomography or magnetic resonance imaging. The tests (TEG and CCT [PT, INR, activated partial thromboplastin time, and platelet count]) were performed preoperatively (on the day of surgery), intraoperatively (2 h into surgery), and postoperatively (the day after surgery).
SPSS Version 21.0 statistical analysis software was used.
We found a universal trend toward hypercoagulability (persistent decrease in R-time, K-time and increase in MA, α-angle, Coagulation Index) in all the TEG parameters measured intraoperatively and postoperatively even though the values were within normal limits. Results of CCT had poor correlation with TEG parameters. The mean intraoperative blood loss was 737.7 ± 185.6 mL, for which PRBC was transfused in 17 patients, FFP in 13, but no platelet transfusion was done intraoperatively.
We found a trend toward hypercoagulability in our study in intraoperative and postoperative period using TEG which was not evident on CCT. TEG was a useful diagnostic tool to identify coagulation abnormalities and to guide perioperative blood transfusion.
与全身性恶性疾病相比,脑肿瘤患者的止血异常更为常见。传统凝血试验(CCT)在动态评估全血凝块强度方面效果不佳。血栓弹力图(TEG)能为我们提供有关凝块形成、稳定和溶解动力学的详细信息,反映止血情况。TEG可评估血栓形成和纤维蛋白溶解。
本研究旨在结合TEG和CCT,调查原发性脑肿瘤手术期间止血状况的时间趋势,并评估围手术期血液成分支持情况。
对40例经计算机断层扫描或磁共振成像显示最大直径大于4 cm的原发性脑肿瘤患者进行了一项前瞻性观察研究。在术前(手术当天)、术中(手术2小时后)和术后(术后第一天)进行检测(TEG和CCT[PT、INR、活化部分凝血活酶时间和血小板计数])。
使用SPSS 21.0版统计分析软件。
我们发现,尽管术中及术后测量的所有TEG参数值均在正常范围内,但仍呈现出普遍的高凝趋势(R时间、K时间持续缩短,MA、α角、凝血指数升高)。CCT结果与TEG参数的相关性较差。术中平均失血量为737.7±185.6 mL,17例患者输注了PRBC,13例输注了FFP,但术中未进行血小板输注。
我们的研究发现,使用TEG在术中及术后呈现出高凝趋势,而CCT未显示出这一趋势。TEG是识别凝血异常和指导围手术期输血的有用诊断工具。